Allurion Technologies Inc. (ALUR)
NYSE: ALUR · Real-Time Price · USD
2.000
-0.110 (-5.21%)
At close: Oct 10, 2025, 4:00 PM EDT
2.010
+0.010 (0.50%)
After-hours: Oct 10, 2025, 7:41 PM EDT
Allurion Technologies Revenue
Allurion Technologies had revenue of $3.38M in the quarter ending June 30, 2025, a decrease of -71.28%. This brings the company's revenue in the last twelve months to $19.92M, down -58.15% year-over-year. In the year 2024, Allurion Technologies had annual revenue of $32.11M, down -39.94%.
Revenue (ttm)
$19.92M
Revenue Growth
-58.15%
P/S Ratio
0.43
Revenue / Employee
$145,380
Employees
137
Market Cap
15.53M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 32.11M | -21.36M | -39.94% |
Dec 31, 2023 | 53.47M | -10.74M | -16.73% |
Dec 31, 2022 | 64.21M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionALUR News
- 5 days ago - Allurion Announces Landmark Peer-Reviewed Publication on Consecutive Use of the Allurion Smart Capsule Showing More Than 20% Weight Loss - Business Wire
- 11 days ago - Allurion to Participate in the ROTH 4th Annual Healthcare Opportunities Conference - Business Wire
- 2 months ago - Allurion Technologies Inc. (ALUR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Allurion Reports Second Quarter 2025 Financial Results and Provides Business Update - Business Wire
- 2 months ago - Allurion to Report Second Quarter 2025 Financial Results on August 13, 2025 - Business Wire
- 2 months ago - Allurion Announces New Strategic Direction With Increasing Focus on Low-Dose GLP-1 Combination Therapy, Muscle Mass Maintenance, and US Market Entry - Business Wire
- 2 months ago - Allurion Announces New Publications on Long-Term Weight Loss Results with the Allurion Program - Business Wire
- 3 months ago - Allurion Announces Strategic Distribution Partnership with Minogue Medical in Canada to Pioneer New Approach Focused on Metabolically Healthy Weight Loss - Business Wire